Back to top
more

Amgen Inc. (AMGN)

(Delayed Data from NSDQ)

$255.97 USD

255.97
2,016,423

+0.26 (0.10%)

Updated Apr 19, 2021 04:00 PM ET

After-Market: $256.05 +0.08 (0.03%) 7:12 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 23% (196 out of 254)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for AMGN More Info

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Amgen Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 10,647 8,911 29,304 41,678 38,085
Receivables 4,525 4,057 3,580 3,237 3,165
Notes Receivable 0 0 0 0 0
Inventories 3,893 3,584 2,940 2,834 2,745
Other Current Assets 2,079 1,888 1,794 1,727 2,015
Total Current Assets 21,144 18,440 37,618 49,476 46,010
Net Property & Equipment 4,889 4,928 4,958 4,989 4,961
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 31,276 34,116 22,142 23,370 25,030
Deposits & Other Assets 5,639 2,223 1,698 2,119 1,625
Total Assets 62,948 59,707 66,416 79,954 77,626
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 1,421 1,371 1,207 1,352 917
Current Portion Long-Term Debt 91 2,953 4,419 1,152 4,403
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 10,141 8,511 7,862 6,516 5,884
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 11,653 12,835 13,488 9,020 11,204
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 606 864 1,166 2,436
Convertible Debt 0 0 0 0 0
Long-Term Debt 32,895 26,950 29,510 34,190 30,193
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 8,991 9,643 10,054 10,337 3,918
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 53,539 50,034 53,916 54,713 47,751
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 31,802 31,531 31,246 30,992 30,784
Capital Surplus 0 0 0 0 0
Retained Earnings -21,408 -21,330 -17,977 -5,072 -438
Other Equity -985 -528 -769 -679 -471
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 9,409 9,673 12,500 25,241 29,875
Total Liabilities & Shareholder's Equity 62,948 59,707 66,416 79,954 77,626
Total Common Equity 9,409 9,673 12,500 25,241 29,875
Shares Outstanding 582.10 594.10 637.20 725.90 743.90
Book Value Per Share 16.16 16.28 19.62 34.77 40.16

Fiscal Year End for Amgen Inc. falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents NA 10,647 12,360 11,421 8,012
Receivables NA 4,525 4,094 5,366 5,009
Notes Receivable NA 0 0 0 0
Inventories NA 3,893 3,942 3,840 3,682
Other Current Assets NA 2,079 2,265 2,268 2,110
Total Current Assets NA 21,144 22,661 22,895 18,813
Net Property & Equipment NA 4,889 4,816 4,843 4,879
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 31,276 31,928 32,626 33,336
Deposits & Other Assets NA 5,639 5,232 4,647 4,641
Total Assets NA 62,948 64,637 65,011 61,669
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,421 1,161 1,150 1,338
Current Portion Long-Term Debt NA 91 91 91 1,840
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 10,141 8,701 9,282 8,649
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 11,653 9,953 10,523 11,827
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 210 259 427
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 32,895 34,196 34,133 30,008
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 9,319 9,437 9,922
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 53,539 53,678 54,352 52,184
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 31,802 31,713 31,610 31,525
Capital Surplus NA 0 0 0 0
Retained Earnings NA -21,408 -19,851 -20,168 -21,378
Other Equity NA -985 -903 -783 -662
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 9,409 10,959 10,659 9,485
Total Liabilities & Shareholder's Equity NA 62,948 64,637 65,011 61,669
Total Common Equity 0 9,409 10,959 10,659 9,485
Shares Outstanding 577.50 582.10 582.10 585.60 588.20
Book Value Per Share 0.00 16.16 18.83 18.20 16.13